Pharmaceuticals Industry Overview
Healthcare sector
Companies
311
Total Market Cap
$5.2T
Median P/E
22.6
P25: 17.5 / P75: 37.6
Median P/B
2.7
P25: 1.3 / P75: 6.6
Median EV/EBITDA
15.2
P25: 10.7 / P75: 28.2
Median ROE
-23.7%
P25: -94.0% / P75: 8.2%
Top Companies by Market Cap(251)
| Ticker | Name | Market Cap |
|---|---|---|
| LLY | ELI LILLY AND COMPANY | $992.4B |
| JNJ | Johnson & Johnson | $598.7B |
| ABBV | AbbVie Inc. | $410.4B |
| PG | PROCTER & GAMBLE CO | $388.6B |
| MRK | Merck & Co., Inc. | $306.1B |
| LIN | Linde plc | $235.4B |
| AMGN | AMGEN INC | $209.2B |
| ABT | Abbott Laboratories | $202.3B |
| GILD | GILEAD SCIENCES, INC. | $184.9B |
| PFE | PFIZER INC | $157.2B |
| BMY | BRISTOL-MYERS SQUIBB COMPANY | $127.0B |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | $126.2B |
| ECL | ECOLAB INC. | $86.9B |
| REGN | REGENERON PHARMACEUTICALS, INC. | $82.6B |
| CL | COLGATE-PALMOLIVE COMPANY | $79.5B |
| APD | AIR PRODUCTS AND CHEMICALS, INC. | $61.4B |
| ZTS | Zoetis Inc. | $55.3B |
| IDXX | IDEXX LABORATORIES INC /DE | $52.4B |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | $44.2B |
| EL | Estee Lauder Companies Inc | $39.6B |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | $39.4B |
| KVUE | Kenvue Inc. | $36.6B |
| INSM | INSMED INCORPORATED | $31.8B |
| BIIB | BIOGEN INC. | $28.2B |
| PPG | PPG INDUSTRIES, INC. | $27.6B |
| CHD | CHURCH & DWIGHT CO., INC. | $24.8B |
| DOW | Dow Inc. | $22.0B |
| UTHR | United Therapeutics Corporation | $21.7B |
| IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | $21.1B |
| ALB | ALBEMARLE CORPORATION | $21.1B |
| MRNA | Moderna, Inc. | $20.9B |
| DD | DUPONT DE NEMOURS, INC. | $20.5B |
| RVMD | Revolution Medicines, Inc. | $19.7B |
| LYB | LyondellBasell Industries N.V. | $18.5B |
| VTRS | VIATRIS INC. | $17.2B |
| CF | CF Industries Holdings, Inc. | $15.5B |
| CLX | THE CLOROX COMPANY | $15.4B |
| RPM | RPM International Inc. | $14.6B |
| NBIX | NEUROCRINE BIOSCIENCES, INC. | $13.3B |
| IONS | IONIS PHARMACEUTICALS, INC. | $13.1B |
| SOLS | Solstice Advanced Materials Inc. | $12.5B |
| BMRN | BioMarin Pharmaceutical Inc | $11.9B |
| JAZZ | Jazz Pharmaceuticals plc | $11.7B |
| EXEL | EXELIXIS, INC. | $11.4B |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | $9.8B |
| IBRX | ImmunityBio, Inc. | $9.6B |
| TECH | BIO-TECHNE CORPORATION | $9.2B |
| PCVX | VAXCYTE, INC. | $8.9B |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | $8.9B |
| MOS | MOSAIC CO | $8.8B |
Related Industries
Source: SEC EDGAR, Polygon.io